New Delhi: Apollo Pharmacy, a division of Apollo Hospitals Enterprise and the country’s largest branded drug retail network with over 1,500 outlets, has temporarily suspended sale of medicines manufactured by Ranbaxy Laboratories. The hospital, however, has not issued any separate advisory to its doctors.
“Our medical committee, which is a very strong committee within Apollo, has reviewed the matter and recommended, as a cautionary measure, we should temporarily suspend sale of Ranbaxy medicines, as we cannot take a chance with patients’ safety,” said Shobana Kamineni, executive director, Apollo Hospitals.
“We have nothing against Ranbaxy but we must respect what our medical committee has ordered… We have asked them (Ranbaxy) to re-certify whatever stocks we have till now,” Kamineni said, adding Apollo Pharmacy would restart sale of Ranbaxy drugs after the company had fulfilled the requirements and satisfied the medical committee. [Source: Business Standard]
“We haven’t suspended the (Ranbaxy) drugs per se, but our medical oversight committee has asked for FDA and Good Manufacturing Practices (GMP) certificate for medicines that we dispense,” said Kamineni.
According to some Apollo Pharmacy outlets in Delhi and Mumbai, an instruction to stop selling Ranbaxy drugs did come on Friday morning but was withdrawn by afternoon. [Source: ET]